Kazumi Sano

695 total citations
29 papers, 585 citations indexed

About

Kazumi Sano is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kazumi Sano has authored 29 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kazumi Sano's work include Cancer therapeutics and mechanisms (11 papers), Drug Transport and Resistance Mechanisms (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Kazumi Sano is often cited by papers focused on Cancer therapeutics and mechanisms (11 papers), Drug Transport and Resistance Mechanisms (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Kazumi Sano collaborates with scholars based in Japan and United States. Kazumi Sano's co-authors include Yoji Ikegami, Toshihisa Ishikawa, Megumi Yoshikawa, Shigeru Kohno, Hiroshi Soda, Mikio Oka, Shinzo Tanabe, Hisahiro Yoshida, Seigo Sawada and Takashi Uesugi and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Kazumi Sano

29 papers receiving 574 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kazumi Sano Japan	12	386	301	101	94	67	29	585
Radka Václavíková Czechia	16	436 1.1×	407 1.4×	55 0.5×	26 0.3×	38 0.6×	23	781
Archie Thurston United States	12	124 0.3×	166 0.6×	60 0.6×	47 0.5×	41 0.6×	18	496
D Mingying China	3	330 0.9×	377 1.3×	38 0.4×	48 0.5×	48 0.7×	5	681
Judit Cserepes Hungary	7	472 1.2×	416 1.4×	45 0.4×	78 0.8×	82 1.2×	10	786
Vincent Bertholet Belgium	10	262 0.7×	389 1.3×	26 0.3×	34 0.4×	48 0.7×	13	665
Liia D. Vainchtein Netherlands	9	268 0.7×	114 0.4×	42 0.4×	61 0.6×	15 0.2×	13	372
Junichi Enokizono Japan	12	335 0.9×	291 1.0×	21 0.2×	155 1.6×	22 0.3×	20	667
Ellen Friche Denmark	16	496 1.3×	500 1.7×	31 0.3×	53 0.6×	44 0.7×	28	733
I. E. L. M. Kuppens Netherlands	8	277 0.7×	168 0.6×	24 0.2×	74 0.8×	38 0.6×	10	392
Heleen A. Bardelmeijer Netherlands	11	414 1.1×	166 0.6×	26 0.3×	157 1.7×	46 0.7×	12	667

Countries citing papers authored by Kazumi Sano

Since Specialization

Citations

This map shows the geographic impact of Kazumi Sano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazumi Sano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazumi Sano more than expected).

Fields of papers citing papers by Kazumi Sano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazumi Sano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazumi Sano. The network helps show where Kazumi Sano may publish in the future.

Co-authorship network of co-authors of Kazumi Sano

This figure shows the co-authorship network connecting the top 25 collaborators of Kazumi Sano. A scholar is included among the top collaborators of Kazumi Sano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazumi Sano. Kazumi Sano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takeda, Yuichiro, Naoki Ishizuka, Kazumi Sano, et al.. (2020). Phase I/II Study of Erlotinib to Determine the Optimal Dose in Patients With Non‐Small Cell Lung Cancer Harboring Only EGFR Mutations. Clinical and Translational Science. 13(6). 1150–1160. 3 indexed citations

Inoue, Yutaka, Takashi Morita, Mari Onozuka, et al.. (2019). Impact of Q141K on the Transport of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors by ABCG2. Cells. 8(7). 763–763. 7 indexed citations

Tago, Hiroshi, et al.. (2019). Can we use a local government institute for the environment in Japan to foster environmental science literacy for sustainability?. Sustainability Science. 15(1). 219–232. 1 indexed citations

Nakamura, Yoichi, Kazumi Sano, Shuntaro Sato, et al.. (2016). Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations. Cancer Chemotherapy and Pharmacology. 78(2). 377–382. 13 indexed citations

Inoue, Yutaka, Yoji Ikegami, Kazumi Sano, et al.. (2013). Gefitinib Enhances the Antitumor Activity of CPT-11 in vitro and in vivo by Inhibiting ABCG2 but Not ABCB1: A New Clue to Circumvent Gastrointestinal Toxicity Risk. Chemotherapy. 59(4). 260–272. 3 indexed citations

Tanuma, Junko, Kazumi Sano, Katsuji Teruya, et al.. (2013). Pharmacokinetics of Rifabutin in Japanese HIV-Infected Patients with or without Antiretroviral Therapy. PLoS ONE. 8(8). e70611–e70611. 11 indexed citations

Nakamura, Yoichi, Kazumi Sano, Yoji Ikegami, et al.. (2013). Phase II trial of erlotinib in patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations: additive analysis of pharmacokinetics. Cancer Chemotherapy and Pharmacology. 72(6). 1299–1304. 12 indexed citations

Hirano, Satoshi, Kazumi Sano, Yuichiro Takeda, et al.. (2012). The pharmacokinetics and long-term therapeutic effects of gefitinib in patients with lung adenocarcinoma harboring the epidermal growth factor receptor(EGFR)mutation.. PubMed. 39(10). 1501–6. 9 indexed citations

Ishikawa, Takashi, Hiroyuki Hirano, Hikaru Saito, et al.. (2012). Quantitative Structure-Activity Relationship (QSAR) Analysis to Predict Drug-Drug Interactions of ABC Transporter ABCG2. Mini-Reviews in Medicinal Chemistry. 12(6). 505–514. 13 indexed citations

10.

Yui, Yoshihiro, Kazuyuki Itoh, Kiyoko Yoshioka, et al.. (2010). Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8. Clinical & Experimental Metastasis. 27(8). 619–630. 29 indexed citations

11.

Nakamura, Yoichi, Kazumi Sano, Hiroshi Soda, et al.. (2010). Pharmacokinetics of Gefitinib Predicts Antitumor Activity for Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(9). 1404–1409. 46 indexed citations

12.

Hirano, Satoshi, Kazumi Sano, Yuichiro Takeda, et al.. (2009). [A case of lung adenocarcinoma successfully treated with dose-reescalated gefitinib after resistance was acquired].. PubMed. 36(8). 1333–6. 2 indexed citations

13.

Ishikawa, Toshihisa, Yoji Ikegami, Kazumi Sano, Hiroshi Nakagawa, & Seigo Sawada. (2005). Transport Mechanism-Based Drug Molecular Design: Novel Camptothecin Analogues to Circumvent ABCG2-associated Drug Resistance of Human Tumor Cells. Current Pharmaceutical Design. 12(3). 313–325. 17 indexed citations

14.

Yoshikawa, Megumi, Yoji Ikegami, Kazuyuki Ishii, et al.. (2004). Novel camptothecin analogues that circumvent ABCG2‐associated drug resistance in human tumor cells. International Journal of Cancer. 110(6). 921–927. 45 indexed citations

15.

Sano, Kazumi, Megumi Yoshikawa, Yoji Ikegami, et al.. (2003). Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives. Journal of Chromatography B. 795(1). 25–34. 24 indexed citations

16.

Sano, Kazumi, Yukari Totsuka, Yoji Ikegami, & Takashi Uesugi. (2002). Metabolism of sulphobromophthalein II. Species differences between rats, guinea-pigs and rabbits. Journal of Pharmacy and Pharmacology. 54(2). 231–239. 10 indexed citations

17.

Nakatomi, Katsumi, Megumi Yoshikawa, Mikio Oka, et al.. (2001). Transport of 7-Ethyl-10-hydroxycamptothecin (SN-38) by Breast Cancer Resistance Protein ABCG2 in Human Lung Cancer Cells. Biochemical and Biophysical Research Communications. 288(4). 827–832. 161 indexed citations

18.

Sano, Kazumi, Yukari Totsuka, Yoji Ikegami, & Takashi Uesugi. (2001). Metabolism of sulphobromophthalein I: positional isomers of sulphobromophthalein monoglutathione conjugate. Journal of Pharmacy and Pharmacology. 53(7). 1015–1020. 1 indexed citations

19.

Uesugi, Takashi, Kazumi Sano, Yoshihiro Uesawa, Yoji Ikegami, & Kiminori Mohri. (1997). Ion-pair reversed-phase high-performance liquid chromatography of adenine nucleotides and nucleoside using triethylamine as a counterion. Journal of Chromatography B Biomedical Sciences and Applications. 703(1-2). 63–74. 54 indexed citations

20.

Sano, Kazumi, et al.. (1992). High-performance liquid chromatographic determination of sulphobromophthalein and its conjugates. Journal of Chromatography B Biomedical Sciences and Applications. 578(1). 63–70. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact